SCHEMBL22540945

SCHEMBL22540945

CC(C)OCc1nnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12590300 0.68 TAAR1 (0.45)
SCHEMBL7939302 0.68 TDP1 (0.33)
SCHEMBL22911357 0.68 PDE9A (0.30)
SCHEMBL24524642 0.67 ADORA3 (0.30)
SCHEMBL21843828 0.65 HRH4 (0.42)
SCHEMBL20150446 0.65
SCHEMBL12590301 0.64 HRH3 (0.53)
SCHEMBL21325359 0.63 KDM1A (0.33)
SCHEMBL13681680 0.63
SCHEMBL20150242 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220194932-A1 IMPROVED INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME STEMSYNERGY THERAPEUTICS, INC. 2022-06-23 US disclosed
WO-2020209933-A1 IMPROVED INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME UNIVERSITY OF MIAMI (US) 2020-10-15 WO disclosed